NCT02418390View on ClinicalTrials.gov

The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

October 8, 2020

Study Completion Date

October 8, 2020

Conditions
Thyroid Cancer, Papillary
Interventions
PROCEDURE

prophylactic central lymph node dissection

dissection of level VI compartment by AAHNS (American association of head and neck surgeons) classification

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02418390 - The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma | Biotech Hunter | Biotech Hunter